Literature DB >> 16316349

Increase in heme oxygenase-1 levels ameliorates renovascular hypertension.

Fady T Botros1, Michal L Schwartzman, Charles T Stier, Alvin I Goodman, Nader G Abraham.   

Abstract

BACKGROUND: The heme oxygenase system (HO-1 and HO-2) catalyzes the conversion of heme to free iron, carbon monoxide (CO), a vasodepressor, and biliverdin, which is further converted to bilirubin, an antioxidant. HO-1 induction has been shown to suppress arachidonic acid metabolism by cytochrome P450 (CYP450) monooxygenases and cyclooxygenases (COX), and to decrease blood pressure in spontaneously hypertensive rats (SHR). The Goldblatt 2K1C model is a model of renovascular hypertension in which there is increased expression of COX-2 in the macula densa and increased renin release from the juxtaglomerular apparatus of the clipped kidney. We examined whether HO-1 overexpression, as a prophylactic approach, would attenuate renovascular hypertension and evaluated potential mechanisms that may account for its effect.
METHODS: 2K1C rats were treated with cobalt protoporphyrin (CoPP) or tin mesoporphyrin (SnMP) one day before surgery and weekly for three weeks thereafter. We measured systolic blood pressure, HO activity, HO-1, HO-2, COX-1 and COX-2 protein expression, heme content, and nitrotyrosine levels as indices of oxidative stress. Urinary prostaglandin excretion (PGE2), plasma renin activity (PRA), and plasma aldosterone levels were also measured.
RESULTS: CoPP administration induced renal HO-1 expression by 20-fold and HO activity by 6-fold. This was associated with a reduction in heme content, nitrotyrosine levels, COX-2 expression and urinary PGE2 excretion, and attenuation of the development of hypertension in the 2K1C rats. There was no decrease in plasma renin activity; however, plasma aldosterone levels were significantly lower. In the 2K1C SnMP-treated rats, blood pressure was significantly higher than that of untreated 2K1C rats throughout the study, and the difference in the size of the smaller left clipped kidney compared to the nonclipped right kidney was significantly increased.
CONCLUSION: These findings define an action of prolonged HO-1 induction to interrupt and counteract the influence of the renin-angiotensin-aldosterone system (RAAS) to increase in blood pressure in the 2K1C model of renovascular hypertension. Multiple mechanisms include a decrease in oxidative stress as indicated by the decrease in cellular heme and nitrotyrosine levels, an anti-inflammatory action as evidenced by a decrease in COX-2 and PGE2, interference with the action of angiontensin II (Ang II) as evidenced by an increase in PRA in the face of a decrease in PGE2 and aldosterone, as well as the inhibition of aldosterone synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316349     DOI: 10.1111/j.1523-1755.2005.00745.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  52 in total

Review 1.  Heme oxygenase, a novel target for the treatment of hypertension and obesity?

Authors:  Peter A Hosick; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

2.  In vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor.

Authors:  Eva Csongradi; Trinity Vera; John M Rimoldi; Rama S V Gadepalli; David E Stec
Journal:  Pharmacol Res       Date:  2010-03-23       Impact factor: 7.658

3.  Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury.

Authors:  Luna Benvenisti-Zarom; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2007-03-24       Impact factor: 5.996

4.  Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Narayana Murali; Anthony J Croatt; Luis A Juncos; Robert P Hebbel; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

5.  Interaction between the heme oxygenase system and aldosterone in hypertension.

Authors:  Joseph Fomusi Ndisang; Ashok Jadhav; Nina Lane
Journal:  Int J Angiol       Date:  2007

Review 6.  The heme oxygenases: important regulators of pregnancy and preeclampsia.

Authors:  Eric M George; Junie P Warrington; Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

Review 7.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

8.  Sorting nexin 1 loss results in increased oxidative stress and hypertension.

Authors:  Jian Yang; Laureano D Asico; Amber L Beitelshees; Jun B Feranil; Xiaoyan Wang; John E Jones; Ines Armando; Santiago G Cuevas; Gary L Schwartz; John G Gums; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle; Rhonda M Cooper-DeHoff; Julie A Johnson; Robin A Felder; Edward J Weinman; Chunyu Zeng; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

9.  Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension.

Authors:  Trinity Vera; Silvia Kelsen; David E Stec
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

10.  Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress.

Authors:  Jian Cao; George Drummond; Kazuyoshi Inoue; Komal Sodhi; Xiao Ying Li; Shinji Omura
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.